The Science doesn’t lie! The management might haha, but positive signs ahead!
- Forums
- ASX - By Stock
- SNT
- Ann: Presentation: Phase 2 study of SNT-5505 in myelofibrosis
SNT
syntara limited
Add to My Watchlist
5.26%
!
6.0¢

Ann: Presentation: Phase 2 study of SNT-5505 in myelofibrosis, page-2
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
6.0¢ |
Change
0.003(5.26%) |
Mkt cap ! $95.85M |
Open | High | Low | Value | Volume |
5.6¢ | 6.0¢ | 5.6¢ | $121.4K | 2.130M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 44638 | 5.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.0¢ | 22888 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 44638 | 0.059 |
2 | 72634 | 0.058 |
5 | 721677 | 0.057 |
3 | 562493 | 0.056 |
2 | 118180 | 0.055 |
Price($) | Vol. | No. |
---|---|---|
0.060 | 27888 | 3 |
0.061 | 48214 | 2 |
0.062 | 1 | 1 |
0.063 | 125100 | 1 |
0.064 | 48000 | 1 |
Last trade - 12.28pm 17/06/2025 (20 minute delay) ? |
Featured News
SNT (ASX) Chart |
The Watchlist
RC1
REDCASTLE RESOURCES LIMITED
Ronald Miller, Non-Executive Director
Ronald Miller
Non-Executive Director
SPONSORED BY The Market Online